MappingLab is a leading enterprise specializing in the R&D of electrophysiological mapping scientific research equipment, co-founded by world-renowned, highly experienced scientists from the University of Oxford and the University of Manchester in the United Kingdom. PEVI Instruments Co. Ltd, Henan serves as MappingLab's translational entity in China, holding the registered trademark of MappingLab for the Chinese market. In late 2023, the company successfully established a localized production line for MappingLab in China.

Our mission is to provide the global community of electrophysiological researchers with the highest-quality mapping systems, and to address the critical challenges in electrophysiological detection across key areas including the fundamental research on the mechanisms of heart diseases, preclinical cardiac safety evaluation of pharmaceuticals, and the electrophysiological testing of induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) and other differentiated cells.

To date, leveraging our robust product advantages, comprehensive professional technical support, extensive practical experience, and a commitment to rigorous customer service, our core products—including Electrical Mapping systems and Optical mapping systems—have been widely adopted by research institutions worldwide. We have forged strategic collaborations with the most esteemed experts in the global electrophysiological research field and established a strong network of authorized equipment distributors.

Additionally, we maintain close academic exchanges with a roster of world-class universities and research institutions, such as the University of Oxford, the University of Manchester, Harvard University, Peking University, the University of Toronto, and the University of Technology Sydney.

At MappingLab, we are unwaveringly dedicated to designing and developing highly automated instruments for researchers across the globe. We uphold a customer-centric approach by empowering .